Closed RFA-DP-19-003 CFDA 93.283 Discretionary

Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts

Posted by Centers for Disease Control and Prevention - ERA

Opportunity snapshot. This Grants.gov announcement — Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts — is cataloged under number RFA-DP-19-003 and tied to CFDA assistance listing 93.283, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on January 4, 2019 and last updated on February 27, 2019. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is $700,000 -- $1,000,000. The agency has projected $10.5 million in total estimated funding for this announcement. It expects to issue 4 awards. If the agency funds the expected 4 awards from the $10.5 million estimated pool, the average award works out to roughly $2.6 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on March 8, 2019. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully — federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed — it helps clarify scope and scoring priorities.

Award Range

$700,000 -- $1,000,000

Close Date

March 8, 2019

Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.

Posted

January 4, 2019

Est. Total Funding

$10,500,000

Expected Awards

4

Instrument

Cooperative Agreement

Description

This NOFO is intended to support research on lupus through a 2-component cooperative agreement:Component A (Longitudinal Studies in Population-based Cohorts of Adults with Lupus: 3 Year Followup):This is a longitudinal followup study designed to support an established, US-based, population-based cohort of adults age 18 and older with diagnosed lupus (systemic lupus erythematosus {SLE} and skin lupus) that includes followup data collected at least once since 2015. The intent of this study is to conduct data collection, building upon the cohort and initial followup activities. This data collection should include four content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that adults with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes.Component B: (A Pediatric Lupus Registry with Longitudinal Follow up):This is a project that will support an existing US-based registry of children age 0-17 years with diagnosed lupus (SLE and skin lupus). The intent of this study is to gather baseline data for children age 0-17 years and follow up data for this cohort for three additional years. The baseline and follow up data should include these 4 content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that children with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes.

Eligibility

00;01;02;04;05;06;07;08;11;12;13;20;22;23;25;99

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Jessie Hood<br/>jvr4@cdc.gov

Key Dates

Posted January 4, 2019
Close Date March 8, 2019
Archive Date April 7, 2019
Last Updated February 27, 2019

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts", offered by Centers for Disease Control and Prevention - ERA. It is associated with CFDA program 93.283. This NOFO is intended to support research on lupus through a 2-component cooperative agreement:Component A (Longitudinal Studies in Population-based Cohorts of Adults with Lupus: 3 Year Followup):This...
Is this opportunity still open?
No, this opportunity is closed. It closed on March 8, 2019. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is $700,000 -- $1,000,000. Total estimated funding: $10,500,000. Expected number of awards: 4.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainGrants Editorial